Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
NVIDIA
NVDA
|
$3.17B |
| 2 |
Ginkgo Bioworks
DNA
|
$1.05B |
| 3 |
Peloton Interactive
PTON
|
$691M |
| 4 |
DoorDash
DASH
|
$456M |
| 5 |
Certara
CERT
|
$393M |
Top Sells
| 1 |
Alibaba
BABA
|
$2.33B |
| 2 |
Tesla
TSLA
|
$1.55B |
| 3 |
Moderna
MRNA
|
$1.41B |
| 4 |
Amazon
AMZN
|
$884M |
| 5 |
NetEase
NTES
|
$692M |
Sector Composition
| 1 | Consumer Discretionary | 27.71% |
| 2 | Healthcare | 26.02% |
| 3 | Technology | 19.32% |
| 4 | Communication Services | 12.04% |
| 5 | Financials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Ginkgo Bioworks
DNA
$750M
| $1.05B | 0.55% | +91,002,810 | New | +$1.05B |
|
52
Albemarle
ALB
$9.99B
| $1B | 0.52% | 4,577,000 -47,140 | -1% | -$10.3M |
|
53
Petrobras
PBR
$79.9B
| $990M | 0.52% | 95,770,837 +5,664,549 | +6% | +$58.6M |
|
|
FRC
54
DELISTED
First Republic Bank
FRC
| $948M | 0.5% | 4,915,997 -77,407 | -2% | -$14.9M |
|
55
Datadog
DDOG
$47.7B
| $942M | 0.49% | 6,667,148 -87,955 | -1% | -$12.4M |
|
56
Estee Lauder
EL
$33B
| $915M | 0.48% | 3,051,450 -28,767 | -0.9% | -$8.63M |
|
57
Beyond Meat
BYND
$192M
| $901M | 0.47% | 8,559,271 +174,778 | +2% | +$18.4M |
|
58
Thermo Fisher Scientific
TMO
$186B
| $855M | 0.45% | 1,497,266 -7,024 | -0.5% | -$4.01M |
|
59
TSMC
TSM
$1.2T
| $827M | 0.43% | 7,408,578 -341,762 | -4% | -$38.2M |
|
60
Booking.com
BKNG
$181B
| $816M | 0.43% | 343,757 -4,069 | -1% | -$9.66M |
|
61
10x Genomics
TXG
$1.74B
| $807M | 0.42% | 5,542,625 +511,629 | +10% | +$74.5M |
|
62
S&P Global
SPGI
$167B
| $802M | 0.42% | 1,888,638 -8,662 | -0.5% | -$3.68M |
|
63
Axon Enterprise
AXON
$58.7B
| $794M | 0.42% | 4,538,658 +9,518 | +0.2% | +$1.67M |
|
64
Teradyne
TER
$18.8B
| $791M | 0.41% | 7,243,278 -701,687 | -9% | -$76.6M |
|
65
Zillow
Z
$20.4B
| $758M | 0.4% | 8,597,495 +620,482 | +8% | +$54.7M |
|
66
Denali Therapeutics
DNLI
$2.23B
| $757M | 0.4% | 15,009,816 -137,797 | -0.9% | -$6.95M |
|
67
Mettler-Toledo International
MTD
$26.8B
| $757M | 0.4% | 549,737 +278 | +0.1% | +$383K |
|
68
ResMed
RMD
$40.2B
| $751M | 0.39% | 2,850,142 -389,947 | -12% | -$103M |
|
69
SiteOne Landscape Supply
SITE
$6.39B
| $746M | 0.39% | 3,738,911 -8,568 | -0.2% | -$1.71M |
|
70
MarketAxess Holdings
MKTX
$6.87B
| $738M | 0.39% | 1,754,514 -20,117 | -1% | -$8.46M |
|
71
STAAR Surgical
STAA
$1.36B
| $702M | 0.37% | 5,464,019 -111,813 | -2% | -$14.4M |
|
72
Broadridge
BR
$29.9B
| $680M | 0.36% | 4,082,706 -33,628 | -0.8% | -$5.6M |
|
73
WIX.com
WIX
$7.85B
| $652M | 0.34% | 3,326,322 -124,875 | -4% | -$24.5M |
|
74
ICICI Bank
IBN
$113B
| $620M | 0.32% | 32,843,613 +704,916 | +2% | +$13.3M |
|
75
Baidu
BIDU
$32.8B
| $591M | 0.31% | 3,842,624 -20,221 | -0.5% | -$3.11M |
|